| 000 | 01547 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513195142.0 | ||
| 264 | 0 | _c19991220 | |
| 008 | 199912s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHu, S | |
| 245 | 0 | 0 |
_aTissue selectivity of antidiabetic agent nateglinide: study on cardiovascular and beta-cell K(ATP) channels. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cDec 1999 |
||
| 300 |
_a1372-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAorta, Thoracic _xdrug effects |
| 650 | 0 | 4 |
_aCarbamates _xpharmacology |
| 650 | 0 | 4 |
_aCardiovascular System _xdrug effects |
| 650 | 0 | 4 |
_aCoronary Vessels _xdrug effects |
| 650 | 0 | 4 |
_aCyclohexanes _xpharmacology |
| 650 | 0 | 4 |
_aGlyburide _xpharmacology |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 650 | 0 | 4 |
_aIslets of Langerhans _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xcytology |
| 650 | 0 | 4 | _aNateglinide |
| 650 | 0 | 4 |
_aPhenylalanine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPiperidines _xpharmacology |
| 650 | 0 | 4 |
_aPotassium Channels _xdrug effects |
| 650 | 0 | 4 | _aPotassium Channels, Inwardly Rectifying |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aSwine |
| 700 | 1 | _aWang, S | |
| 700 | 1 | _aDunning, B E | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 291 _gno. 3 _gp. 1372-9 |
|
| 999 |
_c10522147 _d10522147 |
||